| Full text | |
| Author(s): |
Palameta, Soledad
;
Manrique-Rincon, Andrea J.
;
Toscaro, Jessica M.
;
Semionatto, Isadora F.
;
Fonseca, Matheus C.
;
Rosa, Rhubia S. M.
;
Ruas, Luciana P.
;
Oliveira, Paulo S. L.
;
Bajgelman, Marcio C.
Total Authors: 9
|
| Document type: | Journal article |
| Source: | MOLECULAR THERAPY-ONCOLYTICS; v. 24, p. 13-pg., 2022-03-17. |
| Abstract | |
Therapeutic strategies based on immunomodulation have improved cancer therapy. Most approaches target co-stimulatory pathways or the inhibition of immunosuppressive mechanisms, to enhance immune response and overcome the immune tolerance of tumors. Here, we propose a novel platform to deliver targeted immunomodulatory signaling, enhancing antitumor response. The platform is based on virus-like particles derived from lentiviral capsids. These particles may be engineered to harbor multifunctional ligands on the surface that drive tropism to the tumor site and deliver immunomodulatory signaling, boosting the antitumor response. We generated virus-like particles harboring a PSMA-ligand, TNFSF co-stimulatory ligands 4-1BBL or OX40L, and a membrane-anchored GM-CSF cytokine. The virus-like particles are driven to PSMA-expressing tumors and deliver immunomodulatory signaling from the TNFSF surface ligands and the anchored GM-CSF, inducing T cell proliferation, inhibition of regulatory T cells, and potentiating elimination of tumor cells. The PSMA-targeted particles harboring immunomodulators enhanced antitumor activity in immunocompetent challenged mice and may be explored as a potential tool for cancer immunotherapy. (AU) | |
| FAPESP's process: | 15/01488-2 - Development of strategies for antitumor immunomodulation |
| Grantee: | Marcio Chaim Bajgelman |
| Support Opportunities: | Regular Research Grants |
| FAPESP's process: | 19/04458-8 - Development of biological nanoparticles to boost antitumor immunity |
| Grantee: | Marcio Chaim Bajgelman |
| Support Opportunities: | Regular Research Grants |